Divalproex Sodium Capsule, Coated Pellets
Product Images NDC 17856-0109

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 17856-0109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

17856 0109 01

The label for divalproex sodium delayed-release capsules, USP, sprinkle form, 125 mg strength. It includes a 100-capsule quantity, dosage strength of 125 mg DR cap, and warnings about hazardous material and storage conditions (20° to 25°C). Packaged by Unit Dose Solutions, distributed by Atlantic Biologicals Corp.*

FDA Label Image

Chemical Structure (C5f21d48 4718 4774 Af2c A4ece8b16b5b 01)

Chemical structure of divalproex sodium showing the sodium salt of valproic acid dimer with the carboxylate groups complexed by sodium ions. The structure depicts the repeating unit of the molecule with alkyl side chains and carboxylate groups.*

FDA Label Image

Structured Product Formula For Divalproex (C5f21d48 4718 4774 Af2c A4ece8b16b5b 02)

A line graph comparing the percentage reduction in CPS rate between divalproex sodium delayed-release tablets and placebo. The x-axis shows the percentage of patients from 100 to 0, while the y-axis represents the percent reduction in CPS rate from -100% (worsening) to 100% (improvement). The solid line represents divalproex sodium delayed-release tablets, and the dashed line represents placebo, indicating higher improvement for divalproex sodium over placebo.*

FDA Label Image

Structured Product Formula For Divalproex (C5f21d48 4718 4774 Af2c A4ece8b16b5b 03)

A cumulative distribution plot showing the percentage reduction in CPS rate on the vertical axis versus the percentage of patients on the horizontal axis for divalproex sodium treatment. The graph compares two dose groups: high dose (solid line) and low dose (dashed line). The vertical scale ranges from -100% to 100% reduction, with annotations indicating improvement above 0% and worsening below 0%, while the horizontal axis runs from 100% to 0% of patients.*

FDA Label Image

Divalproex Sprinkle Capsule (C5f21d48 4718 4774 Af2c A4ece8b16b5b 04)

An instructional diagram demonstrating how to open a divalproex sodium capsule and administer its coated pellets. Step-by-step images show twisting the capsule apart, sprinkling contents onto soft food such as applesauce or pudding, and ensuring the mixture is swallowed whole without chewing.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.